Propranolol - USP Method
LC Conditions
Official Method
USP L07
Column
Luna 5 µm C8(2) 100 Å, LC Column 250 x 4.6 mm, Ea
Brand
Luna
Part No
00G-4249-E0
Phase Name
C8(2)
Elution Type
Isocratic
Mobile Phase
A: Water
B: Acetonitrile
C: Methanol with 7mM Sodium lauryl sulfate and 11mM Phosphoric acid
Gradient Profile
Step No.
Time(min)
%A
%B
1
0
30.4
30.4
Flow Rate
1.50 mL/min
Temperature
22°C
Detection
UV-Vis Abs.-Variable Wave.(UV) @ (22°C)
Detection Info
Sample Notes
SecurityGuard™ Guard Cartridge System extends column lifetime. - SecurityGuard Cartridges, C8 4 x 3.0mm, 10/Pk Part No.: AJ0-4290 - Holder Part No.: KJ0-4282
Order Items Used in This Application
- 1. Procainamide
- 2. Propranolol
-OEChem-06211003152D<br><br> 38 38 0 0 0 0 0 0 0999 V2000<br> 2.0000 0.4050 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 2.9050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 0.4050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 -4.0950 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.5981 1.9050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.4641 3.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 3.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 1.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.4641 4.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 4.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 -0.0950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 -1.0950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 -1.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.0000 -1.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 -2.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.0000 -2.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.8660 -3.0950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.8101 1.3224 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.2087 2.0127 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.6762 2.8224 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.0747 3.5127 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1215 3.5127 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.5200 2.8224 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.5200 1.9876 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1215 1.2973 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 6.0841 4.4050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 5.4641 5.0250 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.8441 4.4050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.3520 4.4050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.7320 5.0250 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.1120 4.4050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.2690 0.0950 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.2690 -1.2850 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1.4631 -1.2850 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 4.2690 -2.9050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1.4631 -2.9050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 2.3291 -4.4050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 3.4030 -4.4050 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0<br> 1 11 2 0 0 0 0<br> 2 5 1 0 0 0 0<br> 2 6 1 0 0 0 0<br> 2 7 1 0 0 0 0<br> 3 8 1 0 0 0 0<br> 3 11 1 0 0 0 0<br> 3 32 1 0 0 0 0<br> 4 17 1 0 0 0 0<br> 4 37 1 0 0 0 0<br> 4 38 1 0 0 0 0<br> 5 8 1 0 0 0 0<br> 5 18 1 0 0 0 0<br> 5 19 1 0 0 0 0<br> 6 9 1 0 0 0 0<br> 6 20 1 0 0 0 0<br> 6 21 1 0 0 0 0<br> 7 10 1 0 0 0 0<br> 7 22 1 0 0 0 0<br> 7 23 1 0 0 0 0<br> 8 24 1 0 0 0 0<br> 8 25 1 0 0 0 0<br> 9 26 1 0 0 0 0<br> 9 27 1 0 0 0 0<br> 9 28 1 0 0 0 0<br> 10 29 1 0 0 0 0<br> 10 30 1 0 0 0 0<br> 10 31 1 0 0 0 0<br> 11 12 1 0 0 0 0<br> 12 13 2 0 0 0 0<br> 12 14 1 0 0 0 0<br> 13 15 1 0 0 0 0<br> 13 33 1 0 0 0 0<br> 14 16 2 0 0 0 0<br> 14 34 1 0 0 0 0<br> 15 17 2 0 0 0 0<br> 15 35 1 0 0 0 0<br> 16 17 1 0 0 0 0<br> 16 36 1 0 0 0 0<br>M END
Compound Name
Procainamide
CID
4913
Molecular Formula
C13H21N3O
Molecular Weight
235
No. Hydrogen Bond Acceptors
3
No. Hydrogen Bond Donors
2
Similar Applications
Reversed Phase
Pharmaceutical drug mix using Kinetex 5u C18 100x4.6mm
Kinetex 5 µm C18 100 Å, LC Column 100 x 4.6 mm, Ea
20885
Reversed Phase
KNX 5 Brochure - Pharma mix analysis using Kinetex 5um C18 150x4.6mm
Kinetex 5 µm C18 100 Å, LC Column 150 x 4.6 mm, Ea
20738